ARG1 and chronic myelogenous leukemia, BCR-ABL1 positive: Taken together, anti-tumor reactive T cells in CML may be controlled by multiple immune escape strategies including recruitment of MDSCs, expression of Arg1, PD-L1, PD-1, and sCD25.